RINVOQ Achieved Superiority Versus DUPIXENT® For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis Biotech Investing
Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across United States Biotech Investing
BioHarvest Sciences Inc. Increases Vinia Israel Sales Order Forecast for 4th Quarter - 2020 Biotech Investing
Upadacitinib ) Meets Primary and All Ranked Secondary Endpoints in First Phase 3 Induction Study in Ulcerative Colitis Biotech Investing
Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast Biotech Investing
Amgen's Sotorasib Granted Breakthrough Therapy Designation For Advanced Or Metastatic Non-Small Cell Lung Cancer Patients With KRAS G12C Mutation Biotech Investing
BELLUS Health Announces First Patient Dosed in its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough Biotech Investing
